Evidence map›Paper›PMID 28315978›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2017

The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension.

Zoya Marinova, Susanne Walitza, Edna Grünblatt

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Serotonergic Psychedelics in Neural Plasticity.Frontiers in molecular neuroscience · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zoya MarinovaDepartment of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zürich, Wagistrasse 12, Schlieren, 8952, Zurich, Switzerland. Zoya.Marinova@barmelweid.ch.
Susanne WalitzaDepartment of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zürich, Wagistrasse 12, Schlieren, 8952, Zurich, Switzerland.
Edna GrünblattDepartment of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zürich, Wagistrasse 12, Schlieren, 8952, Zurich, Switzerland. edna.gruenblatt@kjpd.uzh.ch.
University of Zurich · CHETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Decreased neurotrophic factors expression and neurotrophin receptors signalling have repeatedly been reported in association with stress, depression, and neurodegenerative disorders. We have previously identified the hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI) as protective against trophic deprivation-induced cytotoxicity in human neuroblastoma SK-N-SH cells and established the dependence of this effect on the 5-HT

Indexed as

AmphetaminesCell Line, TumorHallucinogensHumansLymphocytesMaleNerve Growth FactorNeuritesNeuronal OutgrowthPhosphorylationReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2BReceptor, trkAReceptor, trkBSerotonin 5-HT2 Receptor AntagonistsYoung Adult4-iodo-2,5-dimethoxyphenylisopropylamineAmphetaminesHallucinogensNerve Growth FactorReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2BReceptor, trkAReceptor, trkBSerotonin 5-HT2 Receptor AntagonistsHallucinogenNeuritesSK-N-SH neuroblastoma cellsTropomyosin-related kinase receptors

Identifiers

PMID28315978
OpenAlexW2595414645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.